Polysaccharide Coated Substrates for Protein Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Protein aggregation and denaturing on substrate surfaces in medical devices and vessels lead to loss of experimental accuracy and pharmaceutical potency, causing adverse immune responses and product withdrawal, due to non-specific protein adsorption and lack of effective surface modifications.
Innovation Solution
A method of coating substrate surfaces with a composition comprising polysaccharides, oligosaccharides, or polyols, which reduces protein and oligonucleotide adsorption and aggregation by treating the substrate with an oxidizing agent and incubating it with the polysaccharide composition, creating a hydrophilic surface that minimizes protein interaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If surface modifications are applied to mitigate protein adsorption, then protein aggregation and denaturing are reduced, but the complexity of manufacturing increases
Solution Approach 1:
The substrate surface is pre-treated with an oxidizing agent before applying the polysaccharide coating. This preliminary oxidation step creates reactive groups on the surface that enhance the bonding and stability of the subsequent polysaccharide layer, ensuring long-term protein resistance without requiring complex multi-step processes
Solution Approach 2:
A polysaccharide coating serves as an intermediary layer between the substrate surface and the protein solution. This biocompatible polysaccharide layer acts as a mediator that prevents direct contact between proteins and the substrate, thereby reducing adsorption and aggregation while maintaining simple manufacturing
2Object-affected harmful factors
If conventional coatings are used to reduce protein adsorption, then some protection is achieved, but protein aggregation and denaturing still occur
Solution Approach 1:
The invention changes the chemical parameters of the coating by using polysaccharides with specific functional groups (hydroxyl, carboxyl, etc.) that create a hydrophilic surface. This parameter change in surface chemistry fundamentally alters protein-surface interactions, reducing both adsorption and the harmful effects of aggregation and denaturing
Solution Approach 2:
The coating comprises a composite of polysaccharide materials that combine multiple beneficial properties: hydrophilicity to reduce adsorption, biocompatibility to prevent denaturing, and chemical stability to prevent aggregation. This composite approach provides comprehensive protection that single-material coatings cannot achieve
3Ease of manufacture
If no surface treatment is applied, then manufacturing is simple, but protein aggregation and denaturing occur causing loss of potency
Solution Approach 1:
The polysaccharide coating is applied specifically to the substrate surface where protein contact occurs, leaving the bulk substrate unchanged. This localized treatment maintains the simplicity of manufacturing while providing targeted protection against protein aggregation and potency loss at the critical interface
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coated substrates significantly reduce protein and oligonucleotide adsorption, enhancing the thermal and intrinsic stability of pharmaceutical compositions, allowing for improved storage conditions and reduced immune responses.
Implementation Method 1
treating at least a portion of the substrate surface with an oxidising agent
Implementation Method 2
treating at least a portion of the substrate surface with a composition comprising a polysaccharide, oligosaccharide, polyol or mixture thereof
Data Source
AI summary
A method of coating a substrate surface, the method comprising: providing a substrate having a surface, optionally, treating at least a portion of the substrate surface with an oxidising agent, treating at least a portion of the substrate surface with a composition comprising a polysaccharide, oligosaccharide, polyol or mixture thereof, and incubating the treated substrate with the composition for a predetermined time. Also disclosed are substrates comprising such a coating, vessels comprising such coated substrates and medicals devices comprising such substrates.